We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,673.00
Bid: 1,674.00
Ask: 1,675.00
Change: 3.00 (0.18%)
Spread: 1.00 (0.06%)
Open: 1,661.50
High: 1,679.50
Low: 1,658.50
Prev. Close: 1,670.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Financials mixed as investor lock in profits

Fri, 22nd Jul 2011 14:18

The financial sector was mixed on Friday, despite rising strongly early on following yesterday's Eurozone deal to bailout Greece. Shares soared on Thursday after the region's leaders agreed a new aid package for Greece and an overhaul of the Eurozone sovereign rescue fund. While RBS bucked the trend amongst financials - with the part-nationalised bank gaining 2.36% to trade at 36.90p - other financial shares lost some of their earlier buoyancy as investors looked to lock in some profits following yesterday's gains. Lloyds and insurance peers Prudential, Old Mutual and Legal & General were prominent among the fallers.Aviva, however, rose higher after takeover rumours regarding the insurance firm resurfaced, citing two European peers (Allianz and Zurich Financial) to be potential suitors. Engineering peers IMI and Weir were among the top performers, gaining 3.48% and 1.93%, respectively.Silver mining giant Fresnillo, too, was a high riser tracking silver prices upwards. Silver futures were 2.52% up at $39.93 at 14:12 on Friday afternoon in London (09:31 in New York).Drugs giants AstraZeneca and GlaxoSmithKline fell into the red after UBS cut its rating on the European pharmaceutical sector from 'small overweight' to 'neutral', saying the defensive sector that benefited from the economic soft patch and the sovereign debt crisis will be hit by the turnaround in these lead indicators. Vodafone was firmer after reporting that revenue from its core business grew by 1.5% in the second quarter of 2011.Outsourcing giant Capita was in demand after the acquisition of the pensions administration and software business of NorthgateArinso for £27.5m.BCFTSE 100 - RisersIMI (IMI) 1,099.00p +3.48%Fresnillo (FRES) 1,687.00p +2.62%Royal Bank of Scotland Group (RBS) 36.90p +2.36%Capita Group (CPI) 700.00p +2.04%Weir Group (WEIR) 2,163.00p +1.93%Marks & Spencer Group (MKS) 360.50p +1.92%Vodafone Group (VOD) 164.25p +1.83%Vedanta Resources (VED) 1,881.00p +1.79%International Consolidated Airlines Group SA (IAG) 242.00p +1.77%WPP (WPP) 734.50p +1.66%FTSE 100 - FallersLloyds Banking Group (LLOY) 46.70p -1.82%Essar Energy (ESSR) 379.00p -1.30%Prudential (PRU) 689.50p -1.29%Old Mutual (OML) 130.00p -1.07%Legal & General Group (LGEN) 116.00p -1.02%Admiral Group (ADM) 1,572.00p -1.01%AstraZeneca (AZN) 3,061.50p -0.99%Rexam (REX) 380.70p -0.91%Investec (INVP) 503.50p -0.89%Amec (AMEC) 1,116.00p -0.80%
More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.